Secular Trends in Procedural Stroke or Death Risks of Stenting Versus Endarterectomy for Symptomatic Carotid Stenosis.

BACKGROUND Over the past decades, stroke risk associated with carotid disease has decreased, reflecting improvements in medical therapy and a more rigorous control of vascular risk factors. It is less clear whether the procedural risk of carotid revascularization has declined over time. METHODS We analyzed temporal changes in procedural risks among 4597 patients with symptomatic carotid stenosis treated with carotid artery stenting (n=2326) or carotid endarterectomy (n=2271) in 4 randomized trials between 2000 and 2008, using generalized linear mixed-effects models with a random intercept for each source trial. Models were additionally adjusted for age and other baseline characteristics predicting treatment risk. The primary outcome event was any procedural stroke or death, occurring during or within 30 days after revascularization. RESULTS The procedural stroke or death risk decreased significantly over time in all patients (unadjusted odds ratio per year, 0.91; 95% CI, 0.85-0.97; P=0.006). This effect was driven by a decrease in the carotid endarterectomy group (unadjusted odds ratio per year, 0.82; 95% CI, 0.73-0.92; P=0.003), whereas no significant decrease was found after carotid artery stenting (unadjusted odds ratio, 0.96; 95% CI, 0.88-1.04; P=0.33). Carotid endarterectomy patients had a lower procedural stroke or death risk compared with carotid artery stenting patients, and the difference significantly increased over time (interaction P=0.031). After adjustment for baseline characteristics, the results remained essentially the same. CONCLUSIONS The risk of stroke or death associated with carotid endarterectomy for symptomatic carotid stenosis decreased over an 8-year period, independent of clinical predictors of procedural risk. No corresponding reduction in procedural risk was seen in patients treated with stenting. CLINICAL TRIAL REGISTRATION URL: https://www.clinicaltrials.gov; http://www.isrctn.com. Unique identifier: NCT00190398 (EVA-3S), NCT00004732 (CREST), ISRCTN57874028 (SPACE), and ISRCTN25337470 (ICSS).

[1]  L. Wilkins.  North American Symptomatic Carotid Endarterectomy Trial. Methods, patient characteristics, and progress. , 1991, Stroke.

[2]  M. Eliasziw,et al.  Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis , 2003, The Lancet.

[3]  S. Gutnikov,et al.  Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study) , 2004, The Lancet.

[4]  G. Chatellier,et al.  Carotid Angioplasty and Stenting With and Without Cerebral Protection: Clinical Alert From the Endarterectomy Versus Angioplasty in Patients With Symptomatic Severe Carotid Stenosis (EVA-3S) Trial , 2004, Stroke.

[5]  P. Rothwell,et al.  Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies , 2004, Neurology.

[6]  S. Gutnikov,et al.  From subgroups to individuals: general principles and the example of carotid endarterectomy , 2005, The Lancet.

[7]  C. Molina,et al.  Patterns and Predictors of Early Risk of Recurrence After Transient Ischemic Attack With Respect to Etiologic Subtypes , 2007, Stroke.

[8]  W. Hacke,et al.  Results of the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: a multinational, prospective, randomised trial , 2008, The Lancet Neurology.

[9]  Hong Wang,et al.  Long-term results of carotid stenting versus endarterectomy in high-risk patients. , 2008, The New England journal of medicine.

[10]  P. Rothwell,et al.  Temporal trends in the risks of stroke and death due to endarterectomy for symptomatic carotid stenosis: an updated systematic review. , 2009, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[11]  Short-term outcome after stenting versus endarterectomy for symptomatic carotid stenosis: a preplanned meta-analysis of individual patient data , 2010, The Lancet.

[12]  P. Rothwell,et al.  Low Risk of Ipsilateral Stroke in Patients With Asymptomatic Carotid Stenosis on Best Medical Treatment: A Prospective, Population-Based Study , 2010, Stroke.

[13]  J. Peinado,et al.  A diffusion-weighted magnetic resonance imaging-based study of transcervical carotid stenting with flow reversal versus transfemoral filter protection. , 2012, Journal of vascular surgery.

[14]  Jaicer Gonçalves Rolo,et al.  Flow Reversal Versus Filter Protection: A Pilot Carotid Artery Stenting Randomized Trial , 2013, Circulation. Cardiovascular interventions.

[15]  김병문,et al.  Incidence of embolism associated with carotid artery stenting: open-cell versus closed-cell stents Clinical article , 2013 .

[16]  Dong Joon Kim,et al.  Incidence of embolism associated with carotid artery stenting: open-cell versus closed-cell stents. , 2013, Journal of neurosurgery.

[17]  A. Owen-Falkenberg,et al.  Urgent Best Medical Therapy May Obviate the Need for Urgent Surgery in Patients With Symptomatic Carotid Stenosis , 2013, Stroke.

[18]  D. Leys,et al.  Long-Term Follow-Up Study of Endarterectomy Versus Angioplasty in Patients With Symptomatic Severe Carotid Stenosis Trial , 2014, Stroke.

[19]  M. Mokin,et al.  Proximal versus distal protection during carotid artery stenting: analysis of the two treatment approaches and associated clinical outcomes. , 2014, World neurosurgery.

[20]  V. Howard,et al.  Temporal Changes in Periprocedural Events in the Carotid Revascularization Endarterectomy Versus Stenting Trial , 2015, Stroke.

[21]  J. Dobson,et al.  Long-Term Outcomes After Stenting Versus Endarterectomy for Treatment of Symptomatic Carotid Stenosis: The International Carotid Stenting Study (ICSS) Randomised Trial , 2015 .

[22]  A. Davies,et al.  Temporal trends in safety of carotid endarterectomy in asymptomatic patients , 2015, Neurology.

[23]  M. Storck,et al.  Patient characteristics and outcomes of carotid endarterectomy and carotid artery stenting: analysis of the German mandatory national quality assurance registry - 2003 to 2014. , 2015, The Journal of cardiovascular surgery.

[24]  P. Dorman,et al.  Long-term outcomes after stenting versus endarterectomy for treatment of symptomatic carotid stenosis: the International Carotid Stenting Study (ICSS) randomised trial , 2015, The Lancet.

[25]  V. Howard,et al.  Long-Term Results of Stenting versus Endarterectomy for Carotid-Artery Stenosis. , 2016, The New England journal of medicine.

[26]  G. Vingerhoets,et al.  Transcervical Carotid Stenting With Dynamic Flow Reversal Demonstrates Embolization Rates Comparable to Carotid Endarterectomy , 2016, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[27]  E. Vicaut,et al.  One-Year Risk of Stroke after Transient Ischemic Attack or Minor Stroke. , 2016, The New England journal of medicine.

[28]  W. Gray,et al.  Randomized Trial of Stent versus Surgery for Asymptomatic Carotid Stenosis. , 2016, The New England journal of medicine.

[29]  E. Mahmud,et al.  Proximal balloon occlusion versus distal filter protection in carotid artery stenting: A meta‐analysis and review of the literature , 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[30]  A. Algra,et al.  Early Endarterectomy Carries a Lower Procedural Risk Than Early Stenting in Patients With Symptomatic Stenosis of the Internal Carotid Artery: Results From 4 Randomized Controlled Trials , 2017, Stroke.

[31]  A. Kuehnl,et al.  Intraoperative Completion Studies, Local Anesthesia, and Antiplatelet Medication Are Associated With Lower Risk in Carotid Endarterectomy , 2017, Stroke.

[32]  A. Algra,et al.  Influence of stent design and use of protection devices on outcome of carotid artery stenting: a pooled analysis of individual patient data , 2018, Journal of NeuroInterventional Surgery.